nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Diseases associated with visual transduction—HSD17B6—ovarian cancer	0.0237	0.189	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.00892	0.0711	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.00803	0.064	CbGpPWpGaD
Gentamicin—LRP2—epithelium—ovarian cancer	0.00704	0.427	CbGeAlD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—ovarian cancer	0.00524	0.0418	CbGpPWpGaD
Gentamicin—LRP2—female reproductive system—ovarian cancer	0.00523	0.317	CbGeAlD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—ovarian cancer	0.00428	0.0342	CbGpPWpGaD
Gentamicin—LRP2—testis—ovarian cancer	0.00422	0.256	CbGeAlD
Gentamicin—Hypomagnesaemia—Epirubicin—ovarian cancer	0.00339	0.00395	CcSEcCtD
Gentamicin—Hearing impaired—Docetaxel—ovarian cancer	0.00335	0.00391	CcSEcCtD
Gentamicin—Hypoaesthesia—Topotecan—ovarian cancer	0.00327	0.00381	CcSEcCtD
Gentamicin—Alopecia—Chlorambucil—ovarian cancer	0.00326	0.0038	CcSEcCtD
Gentamicin—Weight decreased—Vinorelbine—ovarian cancer	0.00318	0.0037	CcSEcCtD
Gentamicin—Phlebitis—Paclitaxel—ovarian cancer	0.00317	0.0037	CcSEcCtD
Gentamicin—Hypomagnesaemia—Doxorubicin—ovarian cancer	0.00313	0.00365	CcSEcCtD
Gentamicin—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00307	0.00358	CcSEcCtD
Gentamicin—Deafness—Paclitaxel—ovarian cancer	0.00305	0.00356	CcSEcCtD
Gentamicin—Stomatitis—Vinorelbine—ovarian cancer	0.00305	0.00356	CcSEcCtD
Gentamicin—Hepatomegaly—Epirubicin—ovarian cancer	0.00304	0.00354	CcSEcCtD
Gentamicin—LRP2—Disease—HSD17B6—ovarian cancer	0.00301	0.024	CbGpPWpGaD
Gentamicin—Anaemia—Chlorambucil—ovarian cancer	0.00297	0.00346	CcSEcCtD
Gentamicin—Agranulocytosis—Vinorelbine—ovarian cancer	0.00292	0.0034	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00292	0.0233	CbGpPWpGaD
Gentamicin—Alopecia—Topotecan—ovarian cancer	0.0029	0.00338	CcSEcCtD
Gentamicin—Visual disturbance—Paclitaxel—ovarian cancer	0.00288	0.00336	CcSEcCtD
Gentamicin—Leukopenia—Chlorambucil—ovarian cancer	0.00287	0.00335	CcSEcCtD
Gentamicin—Alopecia—Melphalan—ovarian cancer	0.00284	0.00331	CcSEcCtD
Gentamicin—Hepatomegaly—Doxorubicin—ovarian cancer	0.00281	0.00328	CcSEcCtD
Gentamicin—Hypoaesthesia—Vinorelbine—ovarian cancer	0.0028	0.00326	CcSEcCtD
Gentamicin—Lethargy—Paclitaxel—ovarian cancer	0.00279	0.00325	CcSEcCtD
Gentamicin—Convulsion—Chlorambucil—ovarian cancer	0.00278	0.00324	CcSEcCtD
Gentamicin—Phlebitis—Docetaxel—ovarian cancer	0.00269	0.00313	CcSEcCtD
Gentamicin—Confusional state—Chlorambucil—ovarian cancer	0.00264	0.00308	CcSEcCtD
Gentamicin—Anaemia—Topotecan—ovarian cancer	0.00264	0.00308	CcSEcCtD
Gentamicin—Injection site pain—Epirubicin—ovarian cancer	0.00264	0.00307	CcSEcCtD
Gentamicin—Deafness—Docetaxel—ovarian cancer	0.00259	0.00302	CcSEcCtD
Gentamicin—Anaemia—Melphalan—ovarian cancer	0.00259	0.00302	CcSEcCtD
Gentamicin—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00257	0.00299	CcSEcCtD
Gentamicin—Leukopenia—Topotecan—ovarian cancer	0.00256	0.00298	CcSEcCtD
Gentamicin—Leukopenia—Melphalan—ovarian cancer	0.00251	0.00292	CcSEcCtD
Gentamicin—Hypokalaemia—Paclitaxel—ovarian cancer	0.00249	0.0029	CcSEcCtD
Gentamicin—Alopecia—Vinorelbine—ovarian cancer	0.00248	0.00289	CcSEcCtD
Gentamicin—Extravasation—Epirubicin—ovarian cancer	0.00247	0.00287	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL6—ovarian cancer	0.00246	0.0196	CbGpPWpGaD
Gentamicin—Erythema—Vinorelbine—ovarian cancer	0.00245	0.00285	CcSEcCtD
Gentamicin—Visual disturbance—Docetaxel—ovarian cancer	0.00244	0.00285	CcSEcCtD
Gentamicin—Injection site pain—Doxorubicin—ovarian cancer	0.00244	0.00284	CcSEcCtD
Gentamicin—Arthralgia—Topotecan—ovarian cancer	0.00243	0.00284	CcSEcCtD
Gentamicin—Convulsion—Melphalan—ovarian cancer	0.00243	0.00283	CcSEcCtD
Gentamicin—Muscular weakness—Paclitaxel—ovarian cancer	0.00241	0.00281	CcSEcCtD
Gentamicin—LRP2—Disease—CHMP4C—ovarian cancer	0.00241	0.0192	CbGpPWpGaD
Gentamicin—Lethargy—Docetaxel—ovarian cancer	0.00236	0.00275	CcSEcCtD
Gentamicin—Hypocalcaemia—Epirubicin—ovarian cancer	0.00235	0.00274	CcSEcCtD
Gentamicin—Oliguria—Epirubicin—ovarian cancer	0.00233	0.00272	CcSEcCtD
Gentamicin—Anaphylactic shock—Topotecan—ovarian cancer	0.00233	0.00272	CcSEcCtD
Gentamicin—LRP2—Metabolism—NME2—ovarian cancer	0.00231	0.0184	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Melphalan—ovarian cancer	0.00228	0.00266	CcSEcCtD
Gentamicin—Thrombocytopenia—Topotecan—ovarian cancer	0.00228	0.00266	CcSEcCtD
Gentamicin—Extravasation—Doxorubicin—ovarian cancer	0.00228	0.00266	CcSEcCtD
Gentamicin—Decreased appetite—Chlorambucil—ovarian cancer	0.00228	0.00266	CcSEcCtD
Gentamicin—Anaemia—Vinorelbine—ovarian cancer	0.00226	0.00263	CcSEcCtD
Gentamicin—Thrombocytopenia—Melphalan—ovarian cancer	0.00224	0.00261	CcSEcCtD
Gentamicin—Vertigo—Vinorelbine—ovarian cancer	0.0022	0.00256	CcSEcCtD
Gentamicin—Leukopenia—Vinorelbine—ovarian cancer	0.00219	0.00255	CcSEcCtD
Gentamicin—Hypocalcaemia—Doxorubicin—ovarian cancer	0.00217	0.00253	CcSEcCtD
Gentamicin—Oliguria—Doxorubicin—ovarian cancer	0.00216	0.00252	CcSEcCtD
Gentamicin—Feeling abnormal—Chlorambucil—ovarian cancer	0.00216	0.00252	CcSEcCtD
Gentamicin—Weight decreased—Paclitaxel—ovarian cancer	0.00214	0.00249	CcSEcCtD
Gentamicin—Hypotension—Melphalan—ovarian cancer	0.00214	0.00249	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00213	0.00248	CcSEcCtD
Gentamicin—Hypertension—Vinorelbine—ovarian cancer	0.00211	0.00246	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HSD17B6—ovarian cancer	0.00211	0.0168	CbGpPWpGaD
Gentamicin—Paraesthesia—Topotecan—ovarian cancer	0.0021	0.00244	CcSEcCtD
Gentamicin—Salivary hypersecretion—Epirubicin—ovarian cancer	0.00209	0.00244	CcSEcCtD
Gentamicin—LRP2—Disease—BCL9—ovarian cancer	0.00209	0.0166	CbGpPWpGaD
Gentamicin—Urticaria—Chlorambucil—ovarian cancer	0.00208	0.00243	CcSEcCtD
Gentamicin—Arthralgia—Vinorelbine—ovarian cancer	0.00208	0.00243	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00208	0.00243	CcSEcCtD
Gentamicin—Body temperature increased—Chlorambucil—ovarian cancer	0.00207	0.00241	CcSEcCtD
Gentamicin—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00206	0.0024	CcSEcCtD
Gentamicin—Stomatitis—Paclitaxel—ovarian cancer	0.00205	0.00239	CcSEcCtD
Gentamicin—Paraesthesia—Melphalan—ovarian cancer	0.00205	0.00239	CcSEcCtD
Gentamicin—Decreased appetite—Topotecan—ovarian cancer	0.00203	0.00236	CcSEcCtD
Gentamicin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.002	0.00233	CcSEcCtD
Gentamicin—Decreased appetite—Melphalan—ovarian cancer	0.00199	0.00231	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00196	0.0156	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00195	0.00228	CcSEcCtD
Gentamicin—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.00193	0.00225	CcSEcCtD
Gentamicin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00193	0.00225	CcSEcCtD
Gentamicin—Feeling abnormal—Topotecan—ovarian cancer	0.00192	0.00224	CcSEcCtD
Gentamicin—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00188	0.00219	CcSEcCtD
Gentamicin—Hypotension—Vinorelbine—ovarian cancer	0.00187	0.00217	CcSEcCtD
Gentamicin—Pruritus—Chlorambucil—ovarian cancer	0.00185	0.00216	CcSEcCtD
Gentamicin—Urticaria—Topotecan—ovarian cancer	0.00185	0.00216	CcSEcCtD
Gentamicin—Body temperature increased—Topotecan—ovarian cancer	0.00184	0.00215	CcSEcCtD
Gentamicin—Visual impairment—Paclitaxel—ovarian cancer	0.00182	0.00212	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00182	0.00212	CcSEcCtD
Gentamicin—Urticaria—Melphalan—ovarian cancer	0.00182	0.00212	CcSEcCtD
Gentamicin—Phlebitis—Epirubicin—ovarian cancer	0.00181	0.00211	CcSEcCtD
Gentamicin—Weight decreased—Docetaxel—ovarian cancer	0.00181	0.00211	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—DLC1—ovarian cancer	0.00179	0.0143	CbGpPWpGaD
Gentamicin—Paraesthesia—Vinorelbine—ovarian cancer	0.00179	0.00209	CcSEcCtD
Gentamicin—Tinnitus—Paclitaxel—ovarian cancer	0.00176	0.00205	CcSEcCtD
Gentamicin—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00175	0.00204	CcSEcCtD
Gentamicin—Vascular purpura—Epirubicin—ovarian cancer	0.00175	0.00203	CcSEcCtD
Gentamicin—Stomatitis—Docetaxel—ovarian cancer	0.00174	0.00203	CcSEcCtD
Gentamicin—Decreased appetite—Vinorelbine—ovarian cancer	0.00174	0.00202	CcSEcCtD
Gentamicin—Hypersensitivity—Topotecan—ovarian cancer	0.00172	0.002	CcSEcCtD
Gentamicin—Hypersensitivity—Melphalan—ovarian cancer	0.00168	0.00196	CcSEcCtD
Gentamicin—Phlebitis—Doxorubicin—ovarian cancer	0.00168	0.00195	CcSEcCtD
Gentamicin—Alopecia—Paclitaxel—ovarian cancer	0.00167	0.00195	CcSEcCtD
Gentamicin—Vomiting—Chlorambucil—ovarian cancer	0.00167	0.00194	CcSEcCtD
Gentamicin—Agranulocytosis—Docetaxel—ovarian cancer	0.00167	0.00194	CcSEcCtD
Gentamicin—Pruritus—Topotecan—ovarian cancer	0.00165	0.00192	CcSEcCtD
Gentamicin—Erythema—Paclitaxel—ovarian cancer	0.00165	0.00192	CcSEcCtD
Gentamicin—Feeling abnormal—Vinorelbine—ovarian cancer	0.00164	0.00192	CcSEcCtD
Gentamicin—Purpura—Epirubicin—ovarian cancer	0.00162	0.00189	CcSEcCtD
Gentamicin—Pruritus—Melphalan—ovarian cancer	0.00162	0.00188	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—ovarian cancer	0.00162	0.00188	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00161	0.00188	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00159	0.0127	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Docetaxel—ovarian cancer	0.00159	0.00186	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—ovarian cancer	0.00159	0.00186	CcSEcCtD
Gentamicin—Urticaria—Vinorelbine—ovarian cancer	0.00159	0.00185	CcSEcCtD
Gentamicin—Body temperature increased—Vinorelbine—ovarian cancer	0.00158	0.00184	CcSEcCtD
Gentamicin—Nausea—Chlorambucil—ovarian cancer	0.00156	0.00181	CcSEcCtD
Gentamicin—LRP2—Disease—PPP1CC—ovarian cancer	0.00155	0.0124	CbGpPWpGaD
Gentamicin—Visual impairment—Docetaxel—ovarian cancer	0.00154	0.0018	CcSEcCtD
Gentamicin—Dizziness—Topotecan—ovarian cancer	0.00154	0.0018	CcSEcCtD
Gentamicin—Anaemia—Paclitaxel—ovarian cancer	0.00152	0.00177	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—ovarian cancer	0.0015	0.00175	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00149	0.00174	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYTB—ovarian cancer	0.00149	0.0118	CbGpPWpGaD
Gentamicin—Vomiting—Topotecan—ovarian cancer	0.00148	0.00173	CcSEcCtD
Gentamicin—Vertigo—Paclitaxel—ovarian cancer	0.00148	0.00172	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—ovarian cancer	0.00147	0.00172	CcSEcCtD
Gentamicin—Leukopenia—Paclitaxel—ovarian cancer	0.00147	0.00172	CcSEcCtD
Gentamicin—Rash—Topotecan—ovarian cancer	0.00147	0.00171	CcSEcCtD
Gentamicin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00147	0.00171	CcSEcCtD
Gentamicin—Dermatitis—Topotecan—ovarian cancer	0.00147	0.00171	CcSEcCtD
Gentamicin—Headache—Topotecan—ovarian cancer	0.00146	0.0017	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—BCL9—ovarian cancer	0.00146	0.0117	CbGpPWpGaD
Gentamicin—Vomiting—Melphalan—ovarian cancer	0.00145	0.00169	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00145	0.0116	CbGpPWpGaD
Gentamicin—Rash—Melphalan—ovarian cancer	0.00144	0.00168	CcSEcCtD
Gentamicin—Dermatitis—Melphalan—ovarian cancer	0.00144	0.00168	CcSEcCtD
Gentamicin—Convulsion—Paclitaxel—ovarian cancer	0.00143	0.00166	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—ovarian cancer	0.00142	0.00166	CcSEcCtD
Gentamicin—Hypertension—Paclitaxel—ovarian cancer	0.00142	0.00166	CcSEcCtD
Gentamicin—Alopecia—Docetaxel—ovarian cancer	0.00142	0.00165	CcSEcCtD
Gentamicin—Pruritus—Vinorelbine—ovarian cancer	0.00141	0.00165	CcSEcCtD
Gentamicin—Arthralgia—Paclitaxel—ovarian cancer	0.0014	0.00163	CcSEcCtD
Gentamicin—Erythema—Docetaxel—ovarian cancer	0.00139	0.00163	CcSEcCtD
Gentamicin—Nausea—Topotecan—ovarian cancer	0.00139	0.00162	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—ovarian cancer	0.00138	0.00161	CcSEcCtD
Gentamicin—Nausea—Melphalan—ovarian cancer	0.00136	0.00158	CcSEcCtD
Gentamicin—Confusional state—Paclitaxel—ovarian cancer	0.00135	0.00158	CcSEcCtD
Gentamicin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00134	0.00156	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—ovarian cancer	0.00134	0.00156	CcSEcCtD
Gentamicin—Dizziness—Vinorelbine—ovarian cancer	0.00132	0.00154	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—ovarian cancer	0.00132	0.00153	CcSEcCtD
Gentamicin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00131	0.00153	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPP1CC—ovarian cancer	0.0013	0.0104	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—BRIP1—ovarian cancer	0.0013	0.0104	CbGpPWpGaD
Gentamicin—Anaemia—Docetaxel—ovarian cancer	0.00129	0.0015	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—ovarian cancer	0.00127	0.00149	CcSEcCtD
Gentamicin—Vomiting—Vinorelbine—ovarian cancer	0.00127	0.00148	CcSEcCtD
Gentamicin—Rash—Vinorelbine—ovarian cancer	0.00126	0.00147	CcSEcCtD
Gentamicin—Dermatitis—Vinorelbine—ovarian cancer	0.00126	0.00147	CcSEcCtD
Gentamicin—Hypotension—Paclitaxel—ovarian cancer	0.00125	0.00146	CcSEcCtD
Gentamicin—Headache—Vinorelbine—ovarian cancer	0.00125	0.00146	CcSEcCtD
Gentamicin—Leukopenia—Docetaxel—ovarian cancer	0.00125	0.00145	CcSEcCtD
Gentamicin—Eosinophilia—Doxorubicin—ovarian cancer	0.00124	0.00144	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00122	0.00143	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—ovarian cancer	0.00122	0.00142	CcSEcCtD
Gentamicin—Convulsion—Docetaxel—ovarian cancer	0.00121	0.00141	CcSEcCtD
Gentamicin—Paraesthesia—Paclitaxel—ovarian cancer	0.00121	0.00141	CcSEcCtD
Gentamicin—Hypertension—Docetaxel—ovarian cancer	0.0012	0.0014	CcSEcCtD
Gentamicin—Arthralgia—Docetaxel—ovarian cancer	0.00119	0.00138	CcSEcCtD
Gentamicin—Nausea—Vinorelbine—ovarian cancer	0.00119	0.00138	CcSEcCtD
Gentamicin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00118	0.00137	CcSEcCtD
Gentamicin—LRP2—Disease—HDAC6—ovarian cancer	0.00118	0.00937	CbGpPWpGaD
Gentamicin—Stomatitis—Epirubicin—ovarian cancer	0.00117	0.00137	CcSEcCtD
Gentamicin—Decreased appetite—Paclitaxel—ovarian cancer	0.00117	0.00136	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—DOK1—ovarian cancer	0.00116	0.00921	CbGpPWpGaD
Gentamicin—Confusional state—Docetaxel—ovarian cancer	0.00115	0.00134	CcSEcCtD
Gentamicin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00114	0.00133	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—ovarian cancer	0.00113	0.00132	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—ovarian cancer	0.00112	0.00131	CcSEcCtD
Gentamicin—Thrombocytopenia—Docetaxel—ovarian cancer	0.00111	0.0013	CcSEcCtD
Gentamicin—Feeling abnormal—Paclitaxel—ovarian cancer	0.00111	0.00129	CcSEcCtD
Gentamicin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00109	0.00127	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PPP1CC—ovarian cancer	0.00109	0.00866	CbGpPWpGaD
Gentamicin—Stomatitis—Doxorubicin—ovarian cancer	0.00109	0.00127	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—ovarian cancer	0.00108	0.00125	CcSEcCtD
Gentamicin—Urticaria—Paclitaxel—ovarian cancer	0.00107	0.00124	CcSEcCtD
Gentamicin—Hypotension—Docetaxel—ovarian cancer	0.00106	0.00124	CcSEcCtD
Gentamicin—Body temperature increased—Paclitaxel—ovarian cancer	0.00106	0.00124	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—ovarian cancer	0.00104	0.00121	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—ovarian cancer	0.00104	0.00121	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00104	0.00121	CcSEcCtD
Gentamicin—Paraesthesia—Docetaxel—ovarian cancer	0.00102	0.00119	CcSEcCtD
Gentamicin—LRP2—Disease—XIAP—ovarian cancer	0.00102	0.00813	CbGpPWpGaD
Gentamicin—Tinnitus—Epirubicin—ovarian cancer	0.00101	0.00117	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000995	0.00116	CcSEcCtD
Gentamicin—LRP2—Disease—SMARCA4—ovarian cancer	0.000993	0.00792	CbGpPWpGaD
Gentamicin—Decreased appetite—Docetaxel—ovarian cancer	0.000989	0.00115	CcSEcCtD
Gentamicin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000989	0.00115	CcSEcCtD
Gentamicin—LRP2—Disease—EREG—ovarian cancer	0.000969	0.00773	CbGpPWpGaD
Gentamicin—Visual impairment—Doxorubicin—ovarian cancer	0.000963	0.00112	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—ovarian cancer	0.000955	0.00111	CcSEcCtD
Gentamicin—Pruritus—Paclitaxel—ovarian cancer	0.00095	0.00111	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000947	0.00755	CbGpPWpGaD
Gentamicin—Erythema—Epirubicin—ovarian cancer	0.000941	0.0011	CcSEcCtD
Gentamicin—Feeling abnormal—Docetaxel—ovarian cancer	0.000938	0.00109	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—ovarian cancer	0.000932	0.00109	CcSEcCtD
Gentamicin—Body temperature increased—Docetaxel—ovarian cancer	0.0009	0.00105	CcSEcCtD
Gentamicin—Dizziness—Paclitaxel—ovarian cancer	0.000888	0.00103	CcSEcCtD
Gentamicin—Alopecia—Doxorubicin—ovarian cancer	0.000883	0.00103	CcSEcCtD
Gentamicin—LRP2—Metabolism—YAP1—ovarian cancer	0.000871	0.00695	CbGpPWpGaD
Gentamicin—Erythema—Doxorubicin—ovarian cancer	0.00087	0.00101	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—ovarian cancer	0.000869	0.00101	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000862	0.00687	CbGpPWpGaD
Gentamicin—Vomiting—Paclitaxel—ovarian cancer	0.000854	0.000995	CcSEcCtD
Gentamicin—LRP2—Disease—FASN—ovarian cancer	0.000848	0.00676	CbGpPWpGaD
Gentamicin—Rash—Paclitaxel—ovarian cancer	0.000847	0.000987	CcSEcCtD
Gentamicin—Dermatitis—Paclitaxel—ovarian cancer	0.000846	0.000986	CcSEcCtD
Gentamicin—Vertigo—Epirubicin—ovarian cancer	0.000845	0.000985	CcSEcCtD
Gentamicin—LRP2—Disease—PARP1—ovarian cancer	0.000844	0.00673	CbGpPWpGaD
Gentamicin—Leukopenia—Epirubicin—ovarian cancer	0.000842	0.000981	CcSEcCtD
Gentamicin—Headache—Paclitaxel—ovarian cancer	0.000841	0.00098	CcSEcCtD
Gentamicin—Hypersensitivity—Docetaxel—ovarian cancer	0.000838	0.000977	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HDAC6—ovarian cancer	0.000823	0.00656	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—ovarian cancer	0.000815	0.00095	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—ovarian cancer	0.000812	0.000946	CcSEcCtD
Gentamicin—LRP2—Disease—SLC2A1—ovarian cancer	0.000806	0.00642	CbGpPWpGaD
Gentamicin—Pruritus—Docetaxel—ovarian cancer	0.000805	0.000938	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—ovarian cancer	0.000804	0.000937	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—ovarian cancer	0.000801	0.000933	CcSEcCtD
Gentamicin—Nausea—Paclitaxel—ovarian cancer	0.000798	0.000929	CcSEcCtD
Gentamicin—Vertigo—Doxorubicin—ovarian cancer	0.000782	0.000911	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—ovarian cancer	0.000779	0.000908	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—ovarian cancer	0.000774	0.000902	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000768	0.000895	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000758	0.00604	CbGpPWpGaD
Gentamicin—Convulsion—Doxorubicin—ovarian cancer	0.000754	0.000879	CcSEcCtD
Gentamicin—Dizziness—Docetaxel—ovarian cancer	0.000753	0.000877	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000752	0.000876	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—ovarian cancer	0.000751	0.000876	CcSEcCtD
Gentamicin—Arthralgia—Doxorubicin—ovarian cancer	0.000741	0.000863	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—YAP1—ovarian cancer	0.000728	0.00581	CbGpPWpGaD
Gentamicin—Vomiting—Docetaxel—ovarian cancer	0.000724	0.000843	CcSEcCtD
Gentamicin—Rash—Docetaxel—ovarian cancer	0.000718	0.000836	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—ovarian cancer	0.000717	0.000836	CcSEcCtD
Gentamicin—Dermatitis—Docetaxel—ovarian cancer	0.000717	0.000835	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—ovarian cancer	0.000716	0.000835	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—XIAP—ovarian cancer	0.000714	0.00569	CbGpPWpGaD
Gentamicin—Headache—Docetaxel—ovarian cancer	0.000713	0.000831	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00071	0.000828	CcSEcCtD
Gentamicin—LRP2—Metabolism—FASN—ovarian cancer	0.00071	0.00566	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000699	0.000815	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC5A5—ovarian cancer	0.000699	0.00557	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SMARCA4—ovarian cancer	0.000695	0.00555	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000695	0.00081	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—ovarian cancer	0.000689	0.000803	CcSEcCtD
Gentamicin—LRP2—Disease—PPP2R1A—ovarian cancer	0.000685	0.00546	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EREG—ovarian cancer	0.000679	0.00541	CbGpPWpGaD
Gentamicin—Nausea—Docetaxel—ovarian cancer	0.000676	0.000788	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC2A1—ovarian cancer	0.000675	0.00538	CbGpPWpGaD
Gentamicin—Decreased appetite—Epirubicin—ovarian cancer	0.000667	0.000778	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—ovarian cancer	0.000664	0.000773	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000661	0.00527	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000647	0.000754	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP1B1—ovarian cancer	0.000647	0.00516	CbGpPWpGaD
Gentamicin—Paraesthesia—Doxorubicin—ovarian cancer	0.000638	0.000743	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PGR—ovarian cancer	0.000636	0.00507	CbGpPWpGaD
Gentamicin—Feeling abnormal—Epirubicin—ovarian cancer	0.000633	0.000737	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000619	0.00494	CbGpPWpGaD
Gentamicin—Decreased appetite—Doxorubicin—ovarian cancer	0.000617	0.00072	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000616	0.00491	CbGpPWpGaD
Gentamicin—Urticaria—Epirubicin—ovarian cancer	0.00061	0.000711	CcSEcCtD
Gentamicin—Body temperature increased—Epirubicin—ovarian cancer	0.000607	0.000707	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000595	0.00475	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000594	0.00473	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PARP1—ovarian cancer	0.000591	0.00472	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000585	0.000682	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPP2R1A—ovarian cancer	0.000574	0.00457	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000571	0.00455	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—ovarian cancer	0.000566	0.000659	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—ovarian cancer	0.000564	0.000658	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—ovarian cancer	0.000561	0.000654	CcSEcCtD
Gentamicin—LRP2—Disease—TERT—ovarian cancer	0.000544	0.00434	CbGpPWpGaD
Gentamicin—Pruritus—Epirubicin—ovarian cancer	0.000543	0.000633	CcSEcCtD
Gentamicin—LRP2—Metabolism—ABCB1—ovarian cancer	0.000533	0.00425	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000523	0.00061	CcSEcCtD
Gentamicin—LRP2—Metabolism—TYMS—ovarian cancer	0.000523	0.00417	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—ovarian cancer	0.000508	0.000592	CcSEcCtD
Gentamicin—LRP2—Disease—CAV1—ovarian cancer	0.000503	0.00401	CbGpPWpGaD
Gentamicin—Pruritus—Doxorubicin—ovarian cancer	0.000503	0.000586	CcSEcCtD
Gentamicin—Vomiting—Epirubicin—ovarian cancer	0.000488	0.000569	CcSEcCtD
Gentamicin—Rash—Epirubicin—ovarian cancer	0.000484	0.000564	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—ovarian cancer	0.000484	0.000564	CcSEcCtD
Gentamicin—Headache—Epirubicin—ovarian cancer	0.000481	0.00056	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PPP2R1A—ovarian cancer	0.00048	0.00382	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6ST—ovarian cancer	0.000477	0.0038	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—ovarian cancer	0.00047	0.000547	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000469	0.00374	CbGpPWpGaD
Gentamicin—LRP2—Disease—APC—ovarian cancer	0.000458	0.00366	CbGpPWpGaD
Gentamicin—Nausea—Epirubicin—ovarian cancer	0.000456	0.000531	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—ovarian cancer	0.000452	0.000526	CcSEcCtD
Gentamicin—Rash—Doxorubicin—ovarian cancer	0.000448	0.000522	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—ovarian cancer	0.000447	0.000521	CcSEcCtD
Gentamicin—Headache—Doxorubicin—ovarian cancer	0.000445	0.000519	CcSEcCtD
Gentamicin—Nausea—Doxorubicin—ovarian cancer	0.000422	0.000492	CcSEcCtD
Gentamicin—LRP2—Metabolism—CAV1—ovarian cancer	0.000422	0.00336	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CD—ovarian cancer	0.000403	0.00321	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000403	0.00321	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—ovarian cancer	0.000384	0.00306	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—ovarian cancer	0.000381	0.00304	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—ovarian cancer	0.000356	0.00284	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CAV1—ovarian cancer	0.000352	0.00281	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTOR—ovarian cancer	0.000351	0.0028	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CB—ovarian cancer	0.000351	0.0028	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ESR1—ovarian cancer	0.00034	0.00271	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CD—ovarian cancer	0.000338	0.00269	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6ST—ovarian cancer	0.000334	0.00266	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1B—ovarian cancer	0.00033	0.00263	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—ovarian cancer	0.000321	0.00256	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—ovarian cancer	0.000321	0.00256	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000313	0.0025	CbGpPWpGaD
Gentamicin—LRP2—Disease—CTNNB1—ovarian cancer	0.000311	0.00248	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—ovarian cancer	0.000304	0.00242	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000302	0.00241	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CB—ovarian cancer	0.000294	0.00235	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—ovarian cancer	0.000282	0.00225	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—ovarian cancer	0.000272	0.00216	CbGpPWpGaD
Gentamicin—LRP2—Disease—NRAS—ovarian cancer	0.000271	0.00216	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK3—ovarian cancer	0.000259	0.00207	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTEN—ovarian cancer	0.000254	0.00203	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—ovarian cancer	0.000252	0.00201	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—ovarian cancer	0.000249	0.00199	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK1—ovarian cancer	0.000247	0.00197	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—ovarian cancer	0.000247	0.00197	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MTOR—ovarian cancer	0.000246	0.00196	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—ovarian cancer	0.000246	0.00196	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000239	0.0019	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—ovarian cancer	0.000236	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—ovarian cancer	0.000233	0.00186	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—ovarian cancer	0.000231	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—ovarian cancer	0.000226	0.0018	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—ovarian cancer	0.000226	0.0018	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—ovarian cancer	0.00022	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—ovarian cancer	0.000218	0.00174	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—ovarian cancer	0.000214	0.00171	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—ovarian cancer	0.000214	0.0017	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—ovarian cancer	0.000213	0.0017	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—ovarian cancer	0.000198	0.00158	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—ovarian cancer	0.000192	0.00153	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—ovarian cancer	0.00019	0.00152	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NRAS—ovarian cancer	0.00019	0.00151	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—ovarian cancer	0.00019	0.00151	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK3—ovarian cancer	0.000182	0.00145	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—ovarian cancer	0.000179	0.00143	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—ovarian cancer	0.000177	0.00141	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—ovarian cancer	0.000175	0.00139	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK1—ovarian cancer	0.000173	0.00138	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—ovarian cancer	0.000173	0.00138	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—ovarian cancer	0.000163	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—ovarian cancer	0.00015	0.0012	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—ovarian cancer	0.000147	0.00117	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—ovarian cancer	0.000145	0.00116	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—ovarian cancer	0.000139	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—ovarian cancer	0.000133	0.00106	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—ovarian cancer	0.000123	0.000977	CbGpPWpGaD
